ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Putting Patients to the Forefront
Featuring commentary from Tom O’Leary in an Irish Times article on the potential of digital technology to create a new patient-centric business model.
Access and Reimbursement for Adoptive T-Cell Transfer Drugs
ICON experts in oncology and pricing & market access share their thoughts on offsetting payer obstacles in this Pharmaceutical Executive article.
Patient Recruitment Tool to Improve Sponsor Visibility
A new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments to support clinical trial recruitment.
Europes New Medical Device Rules
Learn how you can avoid the expected delays and extra costs in your development process under MDR and IVDR Medical Device Regulations.
Bringing Precision Medicine to Traumatic Brain Injury Treatment
Reporting on ICON's contribution to a complex pan-European traumatic brain injury (TBI) research study.
Trending 2018: What Does the Future Hold?
Commentary from PV100 honouree Bill Byrom, on prevailing trends in the industry.
Building a Comprehensive Real World Evidence Strategy
How a fully integrated, multidisciplinary RWE model can save time, money and effort in study development and execution.
A Rare Journey: Managing the Regulatory Landscape
ICON contributes to this article in PharmaVOICE looking at efforts undertaken to progress the development of rare disease drugs.
Adaptive Clinical Trial Designs Are Innovative
Article featuring commentary from Rolf Hövelmann and Parvin Fardipour on tackling the operational challenges of adaptive trials.
Big Changes for EU Medical and In Vitro Diagnostic Device Regulations
MDR and IVDR regulations.